Goldman Sachs Upgrades Johnson & Johnson (JNJ) to Buy; Best New Product Story In Pharma
Go back to Goldman Sachs Upgrades Johnson & Johnson (JNJ) to Buy; Best New Product Story In Pharma| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.83 -0.82 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.65 | 52 Week High | $77.12 | |||
| Open | $64.13 | 52 Week Low | $49.03 | |||
| Day High | $64.33 | P/E | 41.45 | |||
| Day Low | $63.35 | EPS | $1.54 | |||
| Volume | 7,529,798 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 260.35 -1.73 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.08 | 52 Week High | $126.07 | |||
| Open | $260.65 | 52 Week Low | $94.28 | |||
| Day High | $261.71 | P/E | 54.13 | |||
| Day Low | $259.16 | EPS | $4.81 | |||
| Volume | 4,998,268 | |||||
